---
layout: post
title: New Drug Approvals 2012 - Pt. XXVII - Choline C-11
date: '2012-12-11T13:18:00.002Z'
author: Ramesh
tags:
- Radiopharmaceuticals
- 2012 New Drugs
modified_time: '2012-12-11T20:35:56.904Z'
thumbnail: http://3.bp.blogspot.com/-KpNpAmrLdu4/UMYFtAQg5-I/AAAAAAAAAD0/fL6MJnFvs_Y/s72-c/fdfd.png
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-7057006141450332035
blogger_orig_url: http://chembl.blogspot.com/2012/12/new-drug-approvals-2012-pt-xxvii.html
---

<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://www.ebi.ac.uk/chembltools/autoiconlarge/1,1,0,0,1,0,0,0,0" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="46" src="https://www.ebi.ac.uk/chembltools/autoiconlarge/1,1,0,0,1,0,0,0,0" width="400" /></a></div>
<div style="text-align: left;">
<br /></div>
<div style="text-align: justify;">
On September 12, FDA approved&nbsp;Choline C-11, an intravenous&nbsp;<i>radioactive</i> diagnostic agent to be used as <i>tracer</i> during Positron Emission Tomography (<a href="http://en.wikipedia.org/wiki/Positron_emission_tomography" target="_blank">PET</a>) scan to help detect sites of recurrent <a href="http://www.nlm.nih.gov/medlineplus/ency/article/000380.htm" target="_blank">Prostate Cancer</a>&nbsp;(OMIM :&nbsp;<a href="http://omim.org/entry/176807" target="_blank">176807</a>&nbsp;; MeSH :&nbsp;<span style="background-color: white; text-align: -webkit-auto;"><a href="http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&amp;term=D011471" target="_blank">D011471</a></span>)&nbsp;.</div>
<div>
<br />
<a href="http://www.nlm.nih.gov/medlineplus/ency/article/000380.htm" style="text-align: justify;" target="_blank">Prostate cancer</a><span style="text-align: justify;"> is the most common cause of death from cancer in men over age 75, and is rarely found in men younger that 40.&nbsp;Unlike many other cancers, prostate cancer usually progresses very slowly. Sometimes the cancer cells may </span><a href="http://en.wikipedia.org/wiki/Metastasis" style="text-align: justify;" target="_blank">metastasize</a><span style="text-align: justify;"> from the prostate to other parts of body. Overall, it is estimated to be the sixth leading cause of cancer-related death in men.</span></div>
<div>
<br /></div>
<div style="text-align: justify;">
<a href="http://en.wikipedia.org/wiki/Choline" target="_blank">Choline</a> is a naturally occurring component of the numerous Vitamin-B complex, and is necessary for normal cell structure and signalling. Choline C-11 is a radiolabeled synthetic analog of choline that releases a positron by beta decay which can be visualised by PET. Choline is rapidly taken up by the prostate cells and this allows the prostate to be imaged.&nbsp;</div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div>
<br /></div>
<div style="text-align: justify;">
Choline, a precursor molecule essential for the biosynthesis of phospholipids which are the structural components of cell membranes, as well as modulation of trans-membrane signalling. Increased activity of phospholipid synthesis has been associated with increased cell proliferation and the transformation process that occurs in tumour cells.</div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-KpNpAmrLdu4/UMYFtAQg5-I/AAAAAAAAAD0/fL6MJnFvs_Y/s1600/fdfd.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="195" src="http://3.bp.blogspot.com/-KpNpAmrLdu4/UMYFtAQg5-I/AAAAAAAAAD0/fL6MJnFvs_Y/s320/fdfd.png" width="320" /></a></div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="separator" style="clear: both; text-align: justify;">
Choline C-11 is a positron emitting radiopharmaceutical that is used for diagnostic purpose in conjunction with PET imaging. The active ingredient is&nbsp;Choline C-11&nbsp;and each millilitre of the injection contains 148 MBq to 1225 MBq of the active ingredient.</div>
<div class="separator" style="clear: both; text-align: left;">
<br /></div>
<div class="separator" style="clear: both; text-align: left;">
IUPAC Name (Choline) : 2-hydroxy-N,N,N-trimethylethanaminium</div>
<div class="separator" style="clear: both; text-align: left;">
Canonical Smiles :&nbsp;[Cl-].[11CH3][N+](C)(C)CCO</div>
<div class="separator" style="clear: both; text-align: left;">
Standard InChI : 1S/C5H14NO.ClH/c1-6(2,3)4-5-7;/h7H,4-5H2,1-3H3;1H/q+1;/p-1/i1-1;</div>
<div class="separator" style="clear: both; text-align: left;">
<br /></div>
<div class="separator" style="clear: both; text-align: justify;">
Following intravenous administration,&nbsp;Choline C-11&nbsp;distributes mainly to the pancreas, kidney, liver, spleen and colon. The radioactivity accumulated rapidly within the prostate and peak uptake appeared with in 5 mins following the administration.&nbsp;Choline C-11&nbsp;undergoes metabolism resulting in the detection of&nbsp;<span style="font-size: x-small;"><span style="font-family: Calibri; vertical-align: super;">11</span></span>C-betaine as the major metabolite in blood. The rate of excretion of&nbsp;Choline C-11&nbsp;in urine was 0.014 mL/min.</div>
<div class="separator" style="clear: both; text-align: justify;">
<br /></div>
<div>
<span style="text-align: justify;">Choline C-11</span>&nbsp;has been developed and marketed by <a href="http://www.mayoclinic.org/news2012-rst/7157.html" target="_blank">Mayo Clinic</a>.</div>
<div>
<br /></div>
<div>
Full prescribing information is found <a href="http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203155s000lbl.pdf" target="_blank">here</a>.</div>
</div>
